Epigenetic Changes Color the Genomes of People with MS – Jessica Shugart
December 9, 2013
he chemical decorations that adorn DNA could sway the onset or severity of multiple sclerosis just as much as the DNA sequence itself, suggests a study published in Nature Neuroscience.
Four Researchers from Icahn School of Medicine at Mount Sinai Among the 400 Most Highly Influential Biomedical Researchers in the World
November 25, 2013
Powerful researchers include Dr. Dennis S. Charney, Dr. Carlos Cordon-Cardo, Dr. Valentin Fuster, and Dr. Eric J. Nestler.
Two Mount Sinai Physicians Elected to the Institute of Medicine
October 24, 2013
Diane E. Meier, MD and Pamela Sklar, MD, PhD, recognized for Outstanding Professional Achievement and Commitment to Service.
Mount Sinai Researchers Publish New Edition of Psychiatry "Bible"
August 7, 2013
In light of the accelerated pace of discovery in understanding psychiatric illnesses, experts from Mount Sinai have published the 4th edition of Neurobiology of Mental Illness.
Mount Sinai Researchers Provide the First Comprehensive and Prospective Characterization of a Genetic Subtype of Autism
June 11, 2013
First study to describe clinical presentation of Phelan-McDermid Syndrome will help guide future research and clinical care
Pioneering Study Demonstrates Benefit of Imaging Technique in Identifying Mental Illness
June 5, 2013
MRI may be an effective way to diagnose mental illnesses such as bipolar disorder, according to experts from the Icahn School of Medicine at Mount Sinai.
Mount Sinai Researchers Identify Promising Drug Target for Depression
February 17, 2013
Decreased expression of a protein called Rac1 may be a primary cause of depression, according to a new study in human and mouse brains.
Facts about How Mount Sinai is Researching and Treating Brain Diseases
December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases.
Short DNA Strands in the Genome May be Key to Understanding Human Cognition and Diseases
November 20, 2012
Previously discarded, human-specific “junk” DNA represents untapped resource in the study of diseases like Alzheimer’s and autism
Changes in Nerve Cells Caused by Social Isolation May Contribute to the Development of Mental Illness
November 11, 2012
Reduced production of myelin, a type of nerve fiber that is lost in diseases like MS, may also play a role in the development of mental illness.
Mount Sinai Researchers Unveil New Targets for Depression at Neuroscience 2012
October 15, 2012
Scientists presented important discoveries on the involvement of the immune system and dopamine on the onset of depression.
Mount Sinai Researchers Find Brain Mechanism Behind Opioid Addiction
October 5, 2012
Chronic morphine exposure has the opposite effect on the brain compared to cocaine in mice, providing new insight into the basis of opiate addiction
Mount Sinai Researcher Receives Prestigious National Institutes of Health Award
September 13, 2012
Anne Schaefer, MD, PhD, Assistant Professor of Neuroscience and Psychiatry, has been recognized with the Director's New Innovator Award.
The New York Times - Why Fathers Really Matter
September 8, 2012
That food and poison change us is not all that surprising, even if it is surprising how far down the change goes. What is unexpected are the psychological dimensions of epigenetics.
Researchers Identify Area Of The Brain That Processes Empathy
September 1, 2012
An international team led by Mount Sinai School of Medicine has shown that one area of the brain is the only activity center of empathy.
Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice
August 8, 2012
Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease
Wayne Goodman, MD, Receives Career Achievement Award from International OCD Foundation
July 28, 2012
The honor was presented to Dr. Goodman at the 19th Annual International OCD Foundation Conference in Chicago.
Mount Sinai Performs First Imaging Test to Detect Alzheimer's Disease in the Clinical Setting
June 20, 2012
The new technique is expected to play a critical role in Alzheimer's disease diagnosis and in research leading to a cure.
Mount Sinai Researcher Receives Career-Starter Research Grant for 2012-2013
June 20, 2012
Hirofumi Morishita, MD, PhD, receives a Career-Starter Research Grant for 2012-2013 from the Knights Templar Eye Foundation.
Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s
July 18, 2011
Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease.
A Natural Chemical Found in Grape Seeds May Prevent Development or Progression of Alzheimer’s
July 15, 2011
Mount Sinai researchers found that polyphenols, a natural extract found in grapes, may help prevent or treat Alzheimer’s disease.
Mount Sinai Celebrates the “Topping Off” of the New Center for Science and Medicine Building
February 7, 2011
Set to open in 2012, CSM will bring nearly a half-million square-feet of new, state-of-the-art medical research and clinical facilities to Mount Sinai.
Mount Sinai Researchers Find That Little-Studied Gene May Boost Long-Term Memory and Enhance Cognition
January 26, 2011
Treatment with a gene called IGF-II significantly improved long-term memory. When the gene was blocked, long-term memories could not form.
Mount Sinai Researchers Make Groundbreaking Discovery on Origin of Brain’s Immune Cells
October 21, 2010
New study could lead to new treatments for degenerative brain diseases, such as Alzheimer’s, and autoimmune disorders, such as multiple sclerosis.
Mount Sinai Researcher Awarded Renowned Institute of Medicine Prize for Outstanding Achievements in Improving Mental Health
October 11, 2010
Dr. Eric Nestler honored for his work and achievements in addiction science.
Antihypertensive Drugs May Protect against Alzheimer’s Disease and Promote Healthy Memory
June 24, 2010
Researchers at Mount Sinai School of Medicine have found that a blood pressure drug may lessen the impact of Alzheimer’s disease and promote healthy memory.
New Autism Susceptibility Genes Identified; Autism Genome Project Phase 2 Results Published in Nature
June 9, 2010
In collaboration with the Autism Genome Project, Mount Sinai has published phase 2 data on gene variants that may lead to new autism treatments.
Mount Sinai Researchers Identify First Drug to Demonstrate Effect in an Animal Model of a Type of Autism
May 20, 2010
Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of an autism subtype.
Yasmin L. Hurd, PhD, Named Director of MD-PhD Program at Mount Sinai School of Medicine
April 2, 2010
Yasmin L. Hurd, PhD, has been appointed Director of the MD/PhD program at Mount Sinai School of Medicine. Her appointment is effective April 1.
Wayne K. Goodman, MD, Honored with Mysell Lecture By Harvard Medical School
March 24, 2010
Wayne K. Goodman, MD, Chair of the Department of Psychiatry at Mount Sinai, has been selected to deliver the prestigious Mysell Lecture at Harvard.
New Mount Sinai Support Groups Will Address the Needs of Parkinson's and Dystonia Patients and Their Caregivers
January 5, 2010
Mount Sinai launches four new support groups to assist patients with Parkinson's disease and dystonia. Topics of discussion will include nutrition, new therapies, and caregiver needs.
Mount Sinai Researcher Led Study to Determine If Drug Slows Progression of Parkinson's Disease
September 24, 2009
C. Warren Olanow, MD, Professor and Chairman Emeritus, Department of Neurology, led an 18-month study on whether a drug used to treat Parkinson's actually slows disease progression.
Mount Sinai Research Identifies Brain Mechanisms Associated with Borderline Personality Disorder
September 3, 2009
Through real-time imaging, researchers have collected evidence to suggest that neurological networks that help regulate emotion do not activate in patients with borderline personality disorder.
Mount Sinai Finds Differences in Brain Scans of Patients with Borderline Personality Disorder
March 5, 2009
New research conducted by Mount Sinai physicians suggests that the brain activity of people with borderline personality disorder is different from that of people without the disorder.
New Psychiatric Program at The Mount Sinai Medical Center Addresses Special Needs of Multiple Sclerosis Patients
February 26, 2009
The new program provides for an on-site psychiatrist to assist in the identification and management of psychiatric and psychological disorders in patients with MS, including depression.